byiShook Opinion
Jul 24, 2024 - 11:30
Sage Therapeutics said Wednesday its Biogen-partnered treatment for essential tremor failed in a study, leading Sage stock to collapse. The post Sage Therapeutics Collapses 21% After Biogen-Tied Essential Tremor Drug Fails appeared first on Investor's Business Daily.
Sage Therapeutics said Wednesday its Biogen-partnered treatment for essential tremor failed in a study, leading Sage stock to collapse.
The post Sage Therapeutics Collapses 21% After Biogen-Tied Essential Tremor Drug Fails appeared first on Investor's Business Daily.